Researchers trained machine learning (ML) models to analyze RNA molecular signatures in patients’ blood.
Novo Nordisk secures FDA approval of RNAi therapy from $3.3B Dicerna takeover
Two years later, Novo Nordisk’s $3.3 billion buyout of Dicerna Pharmaceuticals’ RNAi platform is beginning to pay off. Novo scored an approval on Monday for
October 3, 2023